Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-16 Sale |
2020-11-18 4:10 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
38 | $223.47 | $8,492 | 28,902 (Direct) |
View |
| 2020-08-06 Sale |
2020-08-10 4:13 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,223 | $271.19 | $331,663 | 36,240 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-05 4:14 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,330 | $278.24 | $648,290 | 33,562 (Direct) |
View |
| 2020-05-15 Sale |
2020-05-19 4:21 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
82 | $284.37 | $23,318 | 28,902 (Direct) |
View |
| 2020-05-12 Sale |
2020-05-14 4:17 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,304 | $287.33 | $374,678 | 43,240 (Direct) |
View |
| 2020-05-06 Sale |
2020-05-08 4:17 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,222 | $272.66 | $333,195 | 37,463 (Direct) |
View |
| 2020-05-04 Sale |
2020-05-06 4:17 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,330 | $260.86 | $607,803 | 35,892 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-03 Option Award |
2021-02-05 4:42 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
32,453 | $0 | 61,355 (Direct) |
View |
| 2020-08-06 Exercise |
2020-08-10 4:13 pm |
N/A 2028-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,223 | $0 | 36,240 (Direct) |
View |
| 2020-08-06 Exercise |
2020-08-10 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,223 | $155.57 | 36,240 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 4:14 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,330 | $86.52 | 33,562 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 4:14 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,330 | $0 | 33,562 (Direct) |
View |
| 2020-05-12 Exercise |
2020-05-14 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,304 | $187.53 | 43,240 (Direct) |
View |
| 2020-05-12 Exercise |
2020-05-14 4:17 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,304 | $0 | 43,240 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-08 4:17 pm |
N/A 2028-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,222 | $0 | 37,463 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-08 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,222 | $155.57 | 37,463 (Direct) |
View |
| 2020-05-04 Exercise |
2020-05-06 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,330 | $86.52 | 35,892 (Direct) |
View |
| 2020-05-04 Exercise |
2020-05-06 4:17 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,330 | $0 | 35,892 (Direct) |
View |